Li QY - Search Results

1

RSK4 knockdown promotes proliferation, migration and metastasis of human breast adenocarcinoma cells.

Zhu J, Li QY, Liu JL, Wei W, Yang HW, Tang W. Zhu J, et al. Among authors: li qy. Oncol Rep. 2015 Dec;34(6):3156-62. doi: 10.3892/or.2015.4291. Epub 2015 Sep 18. Oncol Rep. 2015. PMID: 26397146

2

Clinical efficacy of including capecitabine in neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis of randomized controlled trials.

Li Q, Jiang Y, Wei W, Yang H, Liu J. Li Q, et al. PLoS One. 2013;8(1):e53403. doi: 10.1371/journal.pone.0053403. Epub 2013 Jan 3. PLoS One. 2013. PMID: 23301067 Free PMC article. Review.

3

Frequent epigenetic inactivation of RSK4 by promoter methylation in cancerous and non-cancerous tissues of breast cancer.

Li Q, Jiang Y, Wei W, Ji Y, Gao H, Liu J. Li Q, et al. Med Oncol. 2014 Jan;31(1):793. doi: 10.1007/s12032-013-0793-3. Epub 2013 Dec 11. Med Oncol. 2014. PMID: 24338215

4

Promoter methylation and expression changes of BRCA1 in cancerous tissues of patients with sporadic breast cancer.

Li Q, Wei W, Jiang YI, Yang H, Liu J. Li Q, et al. Oncol Lett. 2015 Apr;9(4):1807-1813. doi: 10.3892/ol.2015.2908. Epub 2015 Jan 27. Oncol Lett. 2015. PMID: 25789047 Free PMC article.

5

Efficacy of vinorelbine-based neoadjuvant chemotherapy in breast cancer: A systematic review and meta-analysis of randomized controlled trials.

Gao H, Li Q, Wei W, Jiang YI, Yang H, Liu J. Gao H, et al. Mol Clin Oncol. 2015 Sep;3(5):1145-1151. doi: 10.3892/mco.2015.576. Epub 2015 Jun 9. Mol Clin Oncol. 2015. PMID: 26623067 Free PMC article.

6

Comparison of the effectiveness and toxicity of neoadjuvant chemotherapy regimens, capecitabine/epirubicin/cyclophosphamide vs 5-fluorouracil/epirubicin/cyclophosphamide, followed by adjuvant, capecitabine/docetaxel vs docetaxel, in patients with operable breast cancer.

Zhang M, Wei W, Liu J, Yang H, Jiang Y, Tang W, Li Q, Liao X. Zhang M, et al. Onco Targets Ther. 2016 Jun 8;9:3443-50. doi: 10.2147/OTT.S104431. eCollection 2016. Onco Targets Ther. 2016. PMID: 27354816 Free PMC article.

7

β-Glucosidase inhibition sensitizes breast cancer to chemotherapy.

Zhou X, Huang Z, Yang H, Jiang Y, Wei W, Li Q, Mo Q, Liu J. Zhou X, et al. Biomed Pharmacother. 2017 Jul;91:504-509. doi: 10.1016/j.biopha.2017.04.113. Epub 2017 May 4. Biomed Pharmacother. 2017. PMID: 28478274

8

Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.

Ji Y, Luo N, Jiang Y, Li Q, Wei W, Yang H, Liu J. Ji Y, et al. J Surg Res. 2017 Jul;215:88-92. doi: 10.1016/j.jss.2017.03.038. Epub 2017 Apr 1. J Surg Res. 2017. PMID: 28688667 Clinical Trial.

9

Aberrant expression of RSK4 in breast cancer and its role in the regulation of tumorigenicity.

Jiang Y, Ye X, Ji Y, Zhou X, Yang H, Wei W, Li Q. Jiang Y, et al. Int J Mol Med. 2017 Sep;40(3):883-890. doi: 10.3892/ijmm.2017.3069. Epub 2017 Jul 17. Int J Mol Med. 2017. PMID: 28731146

10

Comparison of the efficacy and survival analysis of neoadjuvant chemotherapy for Her-2-positive breast cancer.

Li S, Wei W, Jiang Y, Li Q, Huang Q, Yang H, Liu J. Li S, et al. Drug Des Devel Ther. 2018 Sep 21;12:3085-3093. doi: 10.2147/DDDT.S171534. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30275685 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,132 results

Search Page

Filters